Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 68.18.
Forward PE Ratio (68.18) = Close Price ($321.00) / Consensus Forward EPS ($4.71)
FORWARD PE RATIO
68.18
SECTOR MEDIAN · HEALTHCARE
20.29
median of 76 covered companies
CURRENT VS SECTOR MEDIAN
+236.11%
vs the sector median at left
Penumbra, Inc.
Market Cap
$12.64B
Forward PE Ratio
68.18
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Penumbra, Inc. (PEN) | $12.64B | 68.18 |
| Tempus AI, Inc. (TEM)vs › | $12.38B | N/A |
| Baxter International Inc. (BAX)vs › | $13.41B | 12.90 |
| Encompass Health Corporation (EHC)vs › | $11.86B | 19.56 |
| DaVita Inc. (DVA)vs › | $11.48B | 12.13 |
| The Cooper Companies, Inc. (COO)vs › | $13.84B | 15.69 |
| Exelixis, Inc. (EXEL)vs › | $13.89B | 18.54 |
| Align Technology, Inc. (ALGN)vs › | $11.38B | 14.09 |
| Bio-Techne Corporation (TECH)vs › | $11.35B | 37.68 |
| Globus Medical, Inc. (GMED)vs › | $11.13B | 16.57 |
Trailing P/E
78.9
reported TTM EPS
Forward P/E
68.2
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $4.71 implies +15.7% EPS growth vs the reported trailing $4.07.
At today's $321.00 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $4.71 | $4.47 – $4.83 | 5 | 68.2x |
| 2027-12-31 | $5.99 | $5.26 – $6.55 | 7 | 53.6x |
| 2028-12-31 | $6.99 | $6.61 – $7.36 | 3 | 46.0x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
